New York-based Clinilabs, an early phase and specialty CRO, has opened a second phase I unit in southern New Jersey. The 50-bed capacity, 15,000-square-foot Specialty Pharma Phase I Unit features semi-private rooms, a large PK sampling facility, a bioanalytic laboratory, pharmacy and exam rooms.
Since 2001, Clinilabs has completed more than 800 clinical trials involving healthy, adult human volunteers and specialty patient populations. The staff has offered clients the service capacity of a big CRO, priced for early-phase projects. The opening of the New Jersey Specialty Pharma Phase I Unit expands services currently offered at the company’s 50-bed phase I unit in Manhattan, raising total bed capacity to 100.
The two locations will provide first-in-human through end-of-phase II CRO services to single-center and multi-center early-phase studies.